ALS Research Collaboration
  • Home
  • About Us
    • Who we are
    • Our Approach
    • Our Team
    • Our History
  • Our Research
    • Research Focus
    • Participate
    • Studies
    • Current
    • Completed
    • All
    • Publications & Talks
    • Research Vignettes
  • News & Events
  • Support Us
    • Make a donation
  • Contact Us
Select Page

Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches.

by Kyra Johnson | Jul 21, 2022

McMillan CT, Wuu J, Rascovsky K, Cosentino S, Grossman M, Elman L, Quinn C, Rosario L, Stark JH, Granit V, Briemberg H, Chenji S, Dionne A, Genge A, Johnston W, Korngut L, Shoesmith C, Zinman L; Canadian ALS Neuroimaging Consortium (CALSNIC), Kalra S, Benatar M. ...

Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses.

by Kyra Johnson | Jul 21, 2022

Miller RG, Zhang R, Bracci PM, Azhir A, Barohn R, Bedlack R, Benatar M, Berry JD, Cudkowicz M, Kasarskis EJ, Mitsumoto H, Manousakis G, Walk D, Oskarsson B, Shefner J, McGrath MS.  Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis:...

Revealing the mutational spectrum in Southern Africans with amyotrophic lateral sclerosis.

by Kyra Johnson | Jul 21, 2022

Nel M, Mahungu AC, Monnakgotla N, Botha GR, Mulder NJ, Wu G, Rampersaud E, van Blitterswijk M, Wuu J, Cooley A, Myers J, Rademakers R, Taylor JP, Benatar M, Heckmann JM.  Revealing the mutational spectrum in Southern Africans with amyotrophic lateral sclerosis. ...

Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.

by Kyra Johnson | Jul 21, 2022

Shepheard SR, Karnaros V, Benyamin B, Schultz DW, Dubowsky M, Wuu J, Chataway T, Malaspina A, Benatar M, Rogers ML.  Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.  Eur J Neurol. 2022...

Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development.

by Kyra Johnson | Jul 21, 2022

Paganoni S, Berry JD, Quintana M, Macklin E, Saville BR, Detry MA, Chase M, Sherman AV, Yu H, Drake K, Andrews J, Shefner J, Chibnik LB, Vestrucci M, Cudkowicz ME; Healey ALS Platform Trial Study Group.  Adaptive platform trials to transform amyotrophic lateral...
« Older Entries
Next Entries »

Recent Posts

  • Dealing ALS a New Hand
  • Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation
  • UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies
  • ALS Center investigators host first international Pre-Symptomatic ALS Workshop
  • CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant

Recent Comments

    Latest News

    12/07/22

    Dealing ALS a New Hand

    05/07/21

    Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation

    05/06/20

    UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

    How You Can Help

    Participate in Research

    Make a Donation

    ALS Research Collaboration
    University of Miami,
    Department of Neurology
    1120 NW 14th Street
    Miami, FL 33136

    Search our site

    About Us

    • Who We Are
    • Our Approach
    • Our Team
    • Our History

    Our Research

    • Research Focus
    • Participate
    • All Studies
    • Publications and Talks
    • Research Vignettes

    Support Us

    • Make a Donation

    Search our site

    Copyright 2021 ALS Research Collaboration at University of Miami. All Rights Reserved. Branding by MOK2

    /* ----------------------------------------- */ /* View slug: recent-posts - start */ /* ----------------------------------------- */ .recent-posts { width: 100%; height: auto; } .recent-post-item { width: 100%; height: auto; padding-bottom: 10px; border-bottom: 2px solid #80b918; margin-bottom: 10px; } /* ----------------------------------------- */ /* View slug: recent-posts - end */ /* ----------------------------------------- */